Oncology Clinical Trials 2012

The recent breakthroughs in understanding of the molecular biology of cancer have led to an unprecedented number of new targets in oncology drug development. Many of these are already advancing to the clinical stages, making oncology clinical trials the most prevalent across therapeutic areas.  The success of an oncology trial depends on many factors, the most important being the quality of pre-clinical data that provides a testable hypothesis. Biostatistical, scientific, organizational, regulatory, ethical and economic ingredients are equally important for advancing clinical development of a drug.

Who should attend: Scientists, biostatisticians, project managers, research investigators and other specialists involved in oncology clinical trials